KathleenLee(Kiernan)HarndenMDMBA candidate 2022

PubMed

• 147 citations
  Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Nega...
  Francois-Clement Bidard, Virginia G Kaklamani, Patrick Neven, Guillermo Streich, Alberto J Montero, Frédéric Forget, Marie-Ange Mouret-Reynier, Joo Hyuk Sohn, Donatien...> ;Journal of Clinical Oncology. 2022 Oct 1
• 13 citations
  Clinical Practices and Institutional Protocols on Prophylaxis, Monitoring, and Management of Selected Adverse Events Associated with Trastuzumab Deruxtecan.
  Aditya Bardia, Kathleen Harnden, Lauren Mauro, Angela Pennisi, Melissa Armitage, Hatem Soliman> ;The Oncologist. 2022 Aug 5
• 14 citations
  Integration of Multitargeted Polymer-Based Contrast Agents with Photoacoustic Computed Tomography: An Imaging Technique to Visualize Breast Cancer Intratumor Heterogen...
  Lei Li, Deepanjali Patil, Greg Petruncio, Kathleen K Harnden, Jisha V Somasekharan, Mikell Paige, Lihong V. Wang, Carolina Salvador-Morales> ;ACS Nano. 2021 Jan 19
• 5 citations
  Management of Chemotherapy-Induced Nausea and Vomiting with Trastuzumab Deruxtecan: A Case Series.
  Matthew Stankowicz, Lauren Mauro, Kathleen K. Harnden, Angela Pennisi> ;Breast Care. 2021 Jan 1
• 7 citations
  Routine use of zoledronic acid in early-stage breast cancer.
  Kathleen K. Harnden, Kimberly L. Blackwell> ;Journal of the National Comprehensive Cancer Network. 2015 Apr 1
• The anti-non-gal xenoantibody response to xenoantigens on gal knockout pig cells is encoded by a restricted number of germline progenitors.
  Kiernan, K.,Harnden, I.,Gunthart, M.,Gregory, C.,Meisner, J.,Kearns-Jonker, M.> ;Am. J. Transplant.. 2008 Aug 02
• Join now to see all